Tryprostatin A | CAS:171864-80-5 | Manufacturer ChemFaces

Tryprostatin A

ChemFaces products have been cited in many studies from excellent and top scientific journals

Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC

How to Order

Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com

Delivery time

Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal

Citing Use of our Products

More Impact Factor than five Cite...

* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.

According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.

Size /Price /Stock	10 mM * 1 mL in DMSO / Inquiry
Other Packaging	*Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap

Featured Products

More...

Tetrahydrocurcumin

Catalog No: CFN90583
CAS No: 36062-04-1
Price: $30/20mg

Malvidin chloride

Catalog No: CFN92035
CAS No: 643-84-5
Price: $398/10mg

Dimethylacrylshikonin

Catalog No: CFN90164
CAS No: 24502-79-2
Price: $138/20mg

Tanshinone IIB

Catalog No: CFN99820
CAS No: 17397-93-2
Price: $463/5mg

Irigenin

Catalog No: CFN93276
CAS No: 548-76-5
Price: $118/20mg

Eriodictyol

Catalog No: CFN99719
CAS No: 552-58-9
Price: $128/20mg

Aloenin A

Catalog No: CFN93235
CAS No: 38412-46-3
Price: $ / mg

Rebaudioside A

Catalog No: CFN99110
CAS No: 58543-16-1
Price: $40/20mg

Tormentic acid

Catalog No: CFN99434
CAS No: 13850-16-3
Price: $238/10mg

Betulonic acid

Catalog No: CFN98682
CAS No: 4481-62-3
Price: $40/20mg

Description:

Tryprostatin A is an inhibitor of breast cancer resistance protein. Tryprostatin A and tryprostatin B are indole alkaloid-based fungal products that inhibit mammalian cell cycle at the G2/M phase.

Targets:

Topoisomerase | Antifection

In vitro:

Jacobs J Biotechnol Bioeng. 2015 Apr;2(1).

Engineered Production of Tryprostatins in E. coli through Reconstitution of a Partial ftm Biosynthetic Gene Cluster from Aspergillus sp.[Pubmed: 26640821 ]

METHODS AND RESULTS:
Tryprostatin A and B are indole alkaloid-based fungal products that inhibit mammalian cell cycle at the G2/M phase. They are biosynthetic intermediates of fumitremorgins produced by a complex pathway involving a nonribosomal peptide synthetase (FtmA), a prenyltransferase (FtmB), a cytochrome P450 hydroxylase (FtmC), an O-methyltransferase (FtmD), and several additional enzymes. A partial fumitremorgin biosynthetic gene cluster (ftmABCD) from Aspergillus sp. was reconstituted in Escherichia coli BL21(DE3) cells, with or without the co-expression of an Sfp-type phosphopantetheinyltransferase gene (Cv_sfp) from Chromobacterium violaceum No. 968.
CONCLUSIONS:
Several recombinant E. coli strains produced tryprostatin B up to 106 mg/l or Tryprostatin A up to 76 mg/l in the fermentation broth under aerobic condition, providing an effective way to prepare those pharmaceutically important natural products biologically.

Bioorg Med Chem. 2008 Apr 15;16(8):4626-51.

Synthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance protein.[Pubmed: 18321710 ]

Tryprostatin A is an inhibitor of breast cancer resistance protein, consequently a series of structure-activity studies on the cell cycle inhibitory effects of Tryprostatin A analogues as potential antitumor antimitotic agents have been carried out.
METHODS AND RESULTS:
These analogues were assayed for their growth inhibition properties and their ability to perturb the cell cycle in tsFT210 cells. SAR studies resulted in the identification of the essential structural features required for cytotoxic activity. The absolute configuration L-Tyr-L-pro in the diketopiperazine ring along with the presence of the 6-methoxy substituent on the indole moiety of 1 was shown to be essential for dual inhibition of topoisomerase II and tubulin polymerization. Biological evaluation also indicated the presence of the 2-isoprenyl moiety on the indole scaffold of 1 was essential for potent inhibition of cell proliferation. Substitution of the indole N(a)-H in 1 with various alkyl or aryl groups, incorporation of various L-amino acids into the diketopiperazine ring in place of L-proline, and substitution of the 6-methoxy group in 1 with other functionality provided active analogues. The nature of the substituents present on the indole N(a)-H or the indole C-2 position influenced the mechanism of action of these analogues. Analogues 68 (IC(50)=10 microM) and 67 (IC(50)=19 microM) were 7-fold and 3.5-fold more potent, respectively, than 1 (IC(50)=68 microM) in the inhibition of the growth of tsFT210 cells.
CONCLUSIONS:
Diastereomer-2 of tryprostatin B 8 was a potent inhibitor of the growth of three human carcinoma cell lines: H520 (IC(50)=11.9 microM), MCF-7 (IC(50)=17.0 microM) and PC-3 (IC(50)=11.1 microM) and was equipotent with etoposide, a clinically used anticancer agent. Isothiocyanate analogue 71 and 6-azido analogue 72 were as potent as 1 in the tsFT210 cell proliferation and may be useful tools in labeling BCRP.

Tryprostatin A Description

Source:	From Aspergillus fumigatus
Solvent:	Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage:	Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C). Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
After receiving:	The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.

Kinase Assay:

Int J Cancer. 2003 Dec 10;107(5):721-8.

Reversal of breast cancer resistance protein-mediated drug resistance by tryprostatin A.[Pubmed: 14566821]

MDR in human cancers is one of the major causes of failure of chemotherapy. A member of the superfamily of ABC transporters, BCRP, was demonstrated to confer an atypical MDR phenotype to tumor cells.
METHODS AND RESULTS:
To overcome the BCRP-mediated drug resistance, the fungal secondary metabolite TPS-A, a diketopiperazine, was analyzed with regard to its potency to reverse the BCRP-mediated drug-resistant phenotype. At concentrations of 10-50 microM, TPS-A reversed a mitoxantrone-resistant phenotype and inhibited the cellular BCRP-dependent mitoxantrone accumulation in the human gastric carcinoma cell line EPG85-257RNOV, the human breast cancer cell line MCF7/AdrVp (both exhibiting acquired BCRP-mediated MDR) and the BCRP cDNA-transfected breast cancer cell line MCF-7/BCRP clone 8. No cytotoxicity was seen at effective concentrations.
CONCLUSIONS:
These data indicate that TPS-A is a novel BCRP inhibitor.

Product Name	Tryprostatin A
Price:
CAS No.:	171864-80-5
Catalog No.:	CFN96472
Molecular Formula:	C₂₂H₂₇N₃O₃
Molecular Weight:	381.47 g/mol
Purity:	>=98%
Type of Compound:	Alkaloids
Physical Desc.:	Powder
Source:	From Aspergillus fumigatus
Solvent:	Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download:	COA MSDS
Similar structural:	Comparison (Web) (SDF)
Guestbook:

Size /Price /Stock	10 mM * 100 uL in DMSO / Inquiry / In-stock 10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries	Anticancer Compound Library Inhibitors Compound Library Alkaloids Compound Library Topoisomerase Inhibitor Library Antifection Inhibitor Library

	1 mg	5 mg	10 mg	20 mg	25 mg
1 mM	2.6214 mL	13.1072 mL	26.2144 mL	52.4288 mL	65.536 mL
5 mM	0.5243 mL	2.6214 mL	5.2429 mL	10.4858 mL	13.1072 mL
10 mM	0.2621 mL	1.3107 mL	2.6214 mL	5.2429 mL	6.5536 mL
50 mM	0.0524 mL	0.2621 mL	0.5243 mL	1.0486 mL	1.3107 mL
100 mM	0.0262 mL	0.1311 mL	0.2621 mL	0.5243 mL	0.6554 mL

CFN98447	Gardneramine	34274-91-4	412.5	C₂₃H₂₈N₂O₅
CFN96295	Quinamine	464-85-7	312.4	C₁₉H₂₄N₂O₂
CFN96329	Conquinamine	464-86-8	312.4	C₁₉H₂₄N₂O₂
CFN99043	Dihydrocinchonamine	10283-68-8	298.4	C₁₉H₂₆N₂O
CFN98823	Neoechinulin A	51551-29-2	323.4	C₁₉H₂₁N₃O₂
CFN99862	Echinulin	1859-87-6	461.7	C₂₉H₃₉N₃O₂
CFN96445	Voafinidine	180059-77-2	328.45	C₂₀H₂₈N₂O₂
CFN96472	Tryprostatin A	171864-80-5	381.47	C₂₂H₂₇N₃O₃